Xpertise Pharma Private Limited
About Xpertise Pharma Private Limited
Data last updated:
Xpertise Pharma Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 23 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74900PB2013PTC037393. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harpreet Singh Jassal and Satnam Kaur.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at K.No. 603 Phase IV Sector 59, Mohali, Punjab, India – 160055.
As per the financials filed for FY 2017, the company reported a revenue of ₹14.18 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹9.46 Lakh (net margin -66.7%) and EBITDA of -₹6.79 Lakh (EBITDA margin -47.8%).
As per MCA filings, the company has satisfied charges of ₹25 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Xpertise Pharma Private Limited's registered office is in Mohali, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressK.No. 603 Phase IV Sector 59, Mohali, Punjab, India – 160055
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Xpertise Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xpertise Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xpertise Pharma Private Limited, buy the company report.
Financials of Xpertise Pharma Private Limited
FY 2017 filings availableXpertise Pharma Private Limited reported revenue of ₹14.18 Lakh (up 18% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹14.18 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6.79 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹9.46 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -47.8% | ||
| Net Profit Margin | -66.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Xpertise Pharma Private Limited, buy the company report.
Board of directors of Xpertise Pharma Private Limited
Xpertise Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harpreet Singh Jassal | Director | 23 Apr 2013 | 13 Years 6 Months | Current |
| Satnam Kaur | Director | 23 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
Xpertise Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S D Finexpo Commercial (India) Pvt Ltd | ₹14.21 Lakh (FY 2025) | 42.0% | Kolkata, West Bengal, India | |||
| Fido Life Sciences Private Limited | ₹14.2 Lakh (FY 2024) | 2.0% | Baghpat, Uttar Pradesh, India | |||
| Abeers Pharmaceuticals Private Limited | ₹14.2 Lakh (FY 2024) | Delhi, India | ||||
| Kain Cosmeceuticals Private Limited | ₹14.19 Lakh (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Staylife Medical Services Private Limited | ₹14.19 Lakh (FY 2016) | Chennai, Tamil Nadu, India | ||||
| Xpertise Pharma Private Limitedthis company | ₹14.18 Lakh (FY 2017) | -₹9.46 Lakh | -66.7% | 18.0% | Mohali, Punjab, India | |
| Shifa Laboratories Pvt Ltd | ₹14.18 Lakh (FY 2025) | -78.0% | New Delhi, Delhi, India | |||
| Rose Healthcare Private Limited | ₹14.16 Lakh (FY 2018) | 120.0% | Kalyan, Maharashtra, India | |||
| Zarvet Pharma Private Limited | ₹14.16 Lakh (FY 2021) | Noida, Uttar Pradesh, India | ||||
| Heya Foods India Private Limited | ₹14.13 Lakh (FY 2024) | Kollam, Kerala, India | ||||
| Tsar Health Private Limited | ₹14.13 Lakh (FY 2022) | -14.0% | New Delhi, Delhi, India |
To see the full peer comparison of Xpertise Pharma Private Limited, buy the company report.
Auditor
Xpertise Pharma Private Limited is audited by BALWINDER ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALWINDER ASSOCIATES | FY 2017 | 014822N |
Shareholding
The shareholding of Xpertise Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Xpertise Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2014 | 10490103 | Andhra Bank | ₹25 Lakh | Satisfied |
To see the full charge records of Xpertise Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Xpertise Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xpertise Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xpertise Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Xpertise Pharma Private Limited, buy the company report.
Recent activity
Xpertise Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Harpreet Singh Jassal was appointed as Director on 23 Apr 2013.
Frequently asked questions
Xpertise Pharma is an active private limited company based in Mohali, Punjab, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 23 April 2013 (13+ years old) and is registered under CIN U74900PB2013PTC037393.
Xpertise Pharma has 2 current directors:
- Harpreet Singh Jassal - Director
- Satnam Kaur - Director
The latest financial statements of Xpertise Pharma on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
No. Xpertise Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Xpertise Pharma is U74900PB2013PTC037393. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xpertise Pharma was incorporated on 23 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Xpertise Pharma by revenue are S D Finexpo Commercial (India) Pvt Ltd, Fido Life Sciences Private Limited, Abeers Pharmaceuticals Private Limited, Kain Cosmeceuticals Private Limited, Staylife Medical Services Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harpreet Singh Jassal was appointed as Director on 23 Apr 2013. Satnam Kaur was appointed as Director on 23 Apr 2013.
The registered office of Xpertise Pharma is at K.No. 603 Phase IV Sector 59, Mohali, Punjab, India – 160055.
Xpertise Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Xpertise Pharma has no open charges and satisfied charges of ₹25 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
